These findings do not fully support MED12 mutations as a common and early pathological event in these fibroepithelial tumors, as did previous studies showing a high frequency and similar patterns of MED12 mutations in both FAs and various grades of PTs20–22. Here, MED12 is linked to fibroepithelial neoplasm.